HK1126790A1 - Biologically active peptide vapeehptllteaplnpk derivatives - Google Patents

Biologically active peptide vapeehptllteaplnpk derivatives

Info

Publication number
HK1126790A1
HK1126790A1 HK09105461.0A HK09105461A HK1126790A1 HK 1126790 A1 HK1126790 A1 HK 1126790A1 HK 09105461 A HK09105461 A HK 09105461A HK 1126790 A1 HK1126790 A1 HK 1126790A1
Authority
HK
Hong Kong
Prior art keywords
peptide
vapeehptllteaplnpk
derivatives
biologically active
active peptide
Prior art date
Application number
HK09105461.0A
Other languages
English (en)
Inventor
Wai Ming Wong
Kong Lam
Original Assignee
Cms Peptides Patent Holding Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cms Peptides Patent Holding Company Ltd filed Critical Cms Peptides Patent Holding Company Ltd
Publication of HK1126790A1 publication Critical patent/HK1126790A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK09105461.0A 2004-04-28 2009-06-17 Biologically active peptide vapeehptllteaplnpk derivatives HK1126790A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56645504P 2004-04-28 2004-04-28

Publications (1)

Publication Number Publication Date
HK1126790A1 true HK1126790A1 (en) 2009-09-11

Family

ID=34967983

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105461.0A HK1126790A1 (en) 2004-04-28 2009-06-17 Biologically active peptide vapeehptllteaplnpk derivatives

Country Status (18)

Country Link
US (1) US7718764B2 (es)
EP (2) EP2058328B1 (es)
JP (1) JP4689664B2 (es)
KR (1) KR101323771B1 (es)
CN (1) CN1976947B (es)
AT (1) ATE505483T1 (es)
AU (1) AU2005238173B2 (es)
CA (1) CA2564179C (es)
DE (1) DE602005027502D1 (es)
DK (1) DK2058328T3 (es)
ES (1) ES2365084T3 (es)
HK (1) HK1126790A1 (es)
NZ (1) NZ551595A (es)
PT (1) PT2058328E (es)
RU (1) RU2377249C2 (es)
TW (1) TWI353252B (es)
WO (1) WO2005105832A2 (es)
ZA (1) ZA200608865B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018105550A1 (ja) * 2016-12-05 2018-06-14 大塚製薬株式会社 筋萎縮抑制組成物
EP4069714A4 (en) * 2019-12-06 2024-02-21 Cooke Aquaculture Inc. PEPTIDES FOR GLUCOSE REGULATION
CN112812171B (zh) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
JPH08511426A (ja) 1993-06-15 1996-12-03 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 新規の組換え産生性クモシルクアナログ
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
WO1995035389A1 (en) 1994-06-17 1995-12-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for introduction of genetic material into microorganisms and transformants obtained therewith
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
KR100465222B1 (ko) 1995-10-24 2005-05-17 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 평활근세포증식억제활성을갖는조직인자응고계인히비터(tfpi)-유래펩티드
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
US6391585B1 (en) 1997-05-27 2002-05-21 Hanil Synthetic Fiber Co., Ltd. Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
US20040214184A1 (en) * 2001-02-28 2004-10-28 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
ATE466871T1 (de) 2001-07-13 2010-05-15 Cms Peptides Patent Holding Co Biologisch aktive peptide
CN1210294C (zh) 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号21的生物活性肽
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
WO2004055045A1 (ja) * 2002-12-16 2004-07-01 Caf Laboratories Inc. サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン
WO2004055042A1 (en) * 2002-12-18 2004-07-01 Pepharm R & D Limited Biologically active peptide conjugates

Also Published As

Publication number Publication date
TW200538151A (en) 2005-12-01
CN1976947A (zh) 2007-06-06
KR20070004895A (ko) 2007-01-09
DE602005027502D1 (de) 2011-05-26
NZ551595A (en) 2010-04-30
EP1756152A2 (en) 2007-02-28
US20080125372A1 (en) 2008-05-29
AU2005238173A1 (en) 2005-11-10
CA2564179A1 (en) 2005-11-10
TWI353252B (en) 2011-12-01
WO2005105832A2 (en) 2005-11-10
JP2008501642A (ja) 2008-01-24
EP2058328A1 (en) 2009-05-13
WO2005105832A3 (en) 2006-06-22
ZA200608865B (en) 2009-06-24
CN1976947B (zh) 2010-05-05
CA2564179C (en) 2013-08-06
RU2006137699A (ru) 2008-04-27
DK2058328T3 (da) 2011-06-27
AU2005238173B2 (en) 2010-12-23
ES2365084T3 (es) 2011-09-21
EP2058328B1 (en) 2011-04-13
PT2058328E (pt) 2011-07-01
RU2377249C2 (ru) 2009-12-27
US7718764B2 (en) 2010-05-18
JP4689664B2 (ja) 2011-05-25
ATE505483T1 (de) 2011-04-15
KR101323771B1 (ko) 2013-10-29

Similar Documents

Publication Publication Date Title
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
EP1626055A3 (en) Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
WO2006034373A3 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
MXPA05002991A (es) Analogos de ghrh.
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
CA2547990A1 (en) Pharmaceutical compositions and methods for insulin treatment
HK1129571A1 (en) Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia tpo
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
HK1126790A1 (en) Biologically active peptide vapeehptllteaplnpk derivatives
ATE342264T1 (de) Indolderivate und deren verwendung als gnrh antagonisten
WO2004112838A3 (en) Codrugs of diclofenac
SG165397A1 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8- aminocaprylic acid
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
MXPA06003381A (es) Beta aminoacidos terapeuticos.
WO2004081031A3 (en) Thiol-mediated drug attachment to targeting peptides
IL177734A0 (en) Combination of deramciclane and opoids as analgesics
EP1730174A4 (en) PEPTIDE CARRIER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
GB0229022D0 (en) Organic Compounds
WO2005035500A3 (en) Therapeutic agents useful for treating pain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150425